A Novel Paradigm for Heart Failure With Preserved Ejection Fraction

Paulus, Walter J., Tschöpe, Carsten·2013·Journal of the American College of Cardiology

Cited by (1,005)

Items 601–700 of 1,005

  1. Prospective association between handgrip strength and cardiac structure and function in UK adults
    Sebastian E. Beyer, Mihir M. Sanghvi, Nay Aung, Alice Hosking, Jackie A. Cooper, José Miguel Paiva, Aaron Mark Lee, Kenneth Fung, Elena I. Lukaschuk, Valentina Carapella et al. · 2018 · PLoS ONE
  2. Effect of Neladenoson Bialanate on Exercise Capacity Among Patients With Heart Failure With Preserved Ejection Fraction
    Sanjiv Jayendra Shah, Adriaan A. Voors, John J.V. McMurray, Dalane W. Kitzman, Thomas Viethen, Antonieta Bomfim Wirtz, Erya Huang, Akos Ferenc Pap, Scott David Solomon · 2019 · JAMA
  3. Mechanisms of atrial fibrillation in aged rats with heart failure with preserved ejection fraction
    Thássio Mesquita, Rui Zhang, Geoffrey de Couto, Jackelyn Valle, Lizbeth Sanchez, Russell George Rogers, Kevin Holm, Weixin Liu, Eduardo Marbán, Eugenio Cingolani · 2020 · Heart Rhythm
  4. Targeting obesity and diabetes to treat heart failure with preserved ejection fraction
    Altara, Raffaele, Giordano, Mauro, Nordén, Einar S., Cataliotti, Alessandro, Kurdi, Mazen, Bajestani, Saeed N., Booz, George W. · 2017 · Frontiers in Endocrinology
  5. Colchicine alleviates inflammation and improves diastolic dysfunction in heart failure rats with preserved ejection fraction
    Song Shen, Junfeng Duan, Jiaxin Hu, Yu Qi, Lina Kang, Kun Wang, Jianzhou Chen, Xiang Wu, Biao Xu, Rong Gu · 2022 · European Journal of Pharmacology
  6. Sex‐ and Race‐Related Differences in Characteristics and Outcomes of Hospitalizations for Heart Failure With Preserved Ejection Fraction
    Parag Goyal, Tracy K. Paul, Zaid Almarzooq, Janey C. Peterson, Udhay Krishnan, Rajesh V. Swaminathan, Dmitriy N. Feldman, Martin T. Wells, Maria G. Karas, Irina Sobol et al. · 2017 · Journal of the American Heart Association
  7. Role of Adipose Tissue Endothelial ADAM17 in Age-Related Coronary Microvascular Dysfunction
    Huijuan Dou, Attila Fehér, Alec C. Davila, Maritza Josefina Romero, Vijay S Patel, Vinayak M. Kamath, Monika Beck Gooz, Radu Daniel Rudic, Rudolf Lucas, David J. Fulton et al. · 2017 · Arteriosclerosis Thrombosis and Vascular Biology
  8. Incident Heart Failure in Patients With Rheumatoid Arthritis: A Nationwide Cohort Study
    Usman Khalid, Alexander Egeberg, Ole Ahlehoff, Deirdre A. Lane, Gunnar Gislason, Gregory Y.H. Lip, Peter Riis Hansen · 2018 · Journal of the American Heart Association
  9. Gender-related differences in heart failure: beyond the “one-size-fits-all” paradigm
    Annamaria De Bellis, Giulia De Angelis, Enrico Fabris, Antonio Nicola Cannata, Marco Merlo, Gianfranco Sinagra · 2019 · Heart Failure Reviews
  10. Diastolic Determinants of Excess Mortality in Heart Failure With Reduced Ejection Fraction
    Giovanni Benfari, Wayne L. Miller, Clémence Antoine, Andrea Rossi, Grace Lin, Jae K. Oh, Veronique Lee Roger, Prabin Bikram Thapa, Maurice L. Enriquez-Sarano · 2019 · JACC Heart Failure
  11. Iron Deficiency: Impact on Functional Capacity and Quality of Life in Heart Failure with Preserved Ejection Fraction
    A. Alcaide-Aldeano, Alberto Garay, Lidia Alcoberro, Santiago Jiménez‐Marrero, Sergi Yun, Marta Tajes, Elena García‐Romero, Carles Díez‐López, José González‐Costello, Gemma Mateus-Porta et al. · 2020 · Journal of Clinical Medicine
  12. INDIE-HFpEF (Inorganic Nitrite Delivery to Improve Exercise Capacity in Heart Failure With Preserved Ejection Fraction)
    Yogesh N.V. Reddy, Gregory D. Lewis, Sanjiv Jayendra Shah, Martin M. LeWinter, Marc J. Semigran, Víctor G. Dávila‐Román, Kevin Joseph Anstrom, Adrian F. Hernandez, Eugene Braunwald, Margaret M. Redfield et al. · 2017 · Circulation Heart Failure
  13. Obesity-Related Heart Failure with Preserved Ejection Fraction
    Tomonari Harada, Masaru Obokata · 2020 · Heart Failure Clinics
  14. Clinical Phenotypes of Heart Failure With Preserved Ejection Fraction to Select Preclinical Animal Models
    Willem B. van Ham, Elise L. Kessler, Marish I.F.J. Oerlemans, M. Louis Handoko, Joost P. G. Sluijter, Toon A.B. van Veen, Hester M. den Ruijter, Saskia C.A. de Jager · 2022 · JACC Basic to Translational Science
  15. Exosomal microRNAs miR-30d-5p and miR-126a-5p Are Associated with Heart Failure with Preserved Ejection Fraction in STZ-Induced Type 1 Diabetic Rats
    Jiung‐Pang Huang, Chih‐Chun Chang, Chao-Yu Kuo, Kuang-Jing Huang, Etienne Marc Sokal, Kuan‐Hsing Chen, Li‐Man Hung · 2022 · International Journal of Molecular Sciences
  16. Implications of Tricuspid Regurgitation and Right Ventricular Volume Overload in Patients with Heart Failure with Preserved Ejection Fraction
    Karl‐Patrik Kresoja, Sebastian Rosch, Anne Rebecca Schöber, Karl Fengler, Florian Schlotter, Sara Bombace, Paula Sagmeister, Maximilian von Roeder, Tobias Kister, Matthias Gutberlet et al. · 2024 · European Journal of Heart Failure
  17. Variable Contribution of Heart Failure to Quality of Life in Ambulatory Heart Failure With Reduced, Better, or Preserved Ejection Fraction
    Emer Joyce, Christine J. Chung, Sabrina Badloe, Kayode A Odutayo, Akshay Suvas Desai, Michael M. Givertz, Anju Nohria, Neal K. Lakdawala, Garrick C. Stewart, Michelle Young et al. · 2016 · JACC Heart Failure
  18. QRS Duration Is a Predictor of Adverse Outcomes in Heart Failure With Preserved Ejection Fraction
    Jacob Joseph, Brian Lee Claggett, Inder S. Anand, Jerome L. Fleg, Thao Thanh Huynh, Akshay Suvas Desai, Scott David Solomon, Eileen O’Meara, Sonja M. McKinlay, Bertram Pitt et al. · 2016 · JACC Heart Failure
  19. Factors Associated With and Prognostic Implications of Cardiac Troponin Elevation in Decompensated Heart Failure With Preserved Ejection Fraction
    Ambarish Pandey, Harsh B. Golwala, Shubin Sheng, Adam D. DeVore, Adrian F. Hernandez, Deepak L. Bhatt, Paul A. Heidenreich, Clyde W. Yancy, James A. de Lemos, Gregg C. Fonarow · 2016 · JAMA Cardiology
  20. Targeting Endothelial Function to Treat Heart Failure with Preserved Ejection Fraction: The Promise of Exercise Training
    Andreas B. Gevaert, Katrien Lemmens, Christiaan J. Vrints, Emeline M. Van Craenenbroeck · 2017 · Oxidative Medicine and Cellular Longevity
  21. Heart Failure With Preserved Ejection Fraction: Is Ischemia Due to Coronary Microvascular Dysfunction a Mechanistic Factor?
    Islam Y. Elgendy, Carl J. Pepine · 2019 · The American Journal of Medicine
  22. Primary Prevention of Heart Failure in Women
    Melissa A. Daubert, Pamela S. Douglas · 2019 · JACC Heart Failure
  23. The apelinergic system: a perspective on challenges and opportunities in cardiovascular and metabolic disorders
    Éric Marsault, Catherine Llorens‐Cortés, Xavier Iturrioz, Hyung J. Chun, Olivier Lesur, Gavin Y. Oudit, Mannix Auger‐Messier · 2019 · Annals of the New York Academy of Sciences
  24. Control strategies in systemic metabolism
    Jessica Jane Ye, Ruslan M. Medzhitov · 2019 · Nature Metabolism
  25. Follistatin like 1 regulates hypertrophy in heart failure with preserved ejection fraction
    Tanaka, Komei, Valero-Muñoz, María, Wilson, Richard M., Essick, Eric E., Fowler, Conor T., Nakamura, Kazuto, van den Hoff, Maurice, Ouchi, Noriyuki, Sam, Flora · 2016 · JACC Basic to Translational Science
  26. Adverse Outcomes Associated With Interleukin-6 in Patients Recently Hospitalized for Heart Failure With Preserved Ejection Fraction
    Leanne Mooney, Colette E. Jackson, Carly Adamson, Alex McConnachie, Paul I. Welsh, Rachel C. Myles, John J.V. McMurray, Pardeep S. Jhund, Mark Colquhoun Petrie, Ninian N. Lang · 2023 · Circulation Heart Failure
  27. Obesity, Heart Failure with Preserved Ejection Fraction, and the Role of Glucagon-Like Peptide-1 Receptor Agonists
    Giuliana Cimino, Muthiah Vaduganathan, Carlo Lombardi, Matteo Pagnesi, Enrico Vizzardi, Daniela Tomasoni, Marianna Adamo, Marco Metra, Riccardo Maria Inciardi · 2023 · ESC Heart Failure
  28. Chinese expert consensus on the diagnosis and treatment of coronary microvascular diseases (2023 Edition)
    Wenqiang Chen, Mei Ni, He Huang, Hongliang Cong, Xianghua Fu, Wei Dong Gao, Yuejin Yang, Mengyue Yu, Xiantao Song, Meilin Liu et al. · 2023 · MedComm
  29. Heart Failure with Preserved Ejection Fraction: Current Understandings and Challenges
    Mads Jønsson Andersen, Barry A. Borlaug · 2014 · Current Cardiology Reports
  30. Relationship of hyperuricemia with mortality in heart failure patients with preserved ejection fraction
    Takeshi Shimizu, Akiomi Yoshihisa, Yuki Kanno, Mai Takiguchi, Akihiko Sato, Shunsuke Miura, Yuichi Nakamura, H. Yamauchi, Takashi Owada, Satoshi Abe et al. · 2015 · American Journal of Physiology-Heart and Circulatory Physiology
  31. Survival After Coronary Artery Bypass Grafting in Patients With Preoperative Heart Failure and Preserved vs Reduced Ejection Fraction
    Magnus Dalén, Lars H. Lund, Torbjörn Ivert, Martin J. Holzmann, Ulrik Sartipy · 2016 · JAMA Cardiology
  32. Novel applications for serum procalcitonin testing in clinical practice
    Justin J. Choi, Matthew William McCarthy · 2017 · Expert Review of Molecular Diagnostics
  33. The heart failure burden of type 2 diabetes mellitus—a review of pathophysiology and interventions
    Anne Pernille Ofstad, Dan Atar, Lars Lysgaard Gullestad, Gisle Langslet, Odd Erik Johansen · 2018 · Heart Failure Reviews
  34. OPLAH ablation leads to accumulation of 5-oxoproline, oxidative stress, fibrosis, and elevated fillings pressures: a murine model for heart failure with a preserved ejection fraction
    Atze van der Pol, Andrés Gil, Jasper Tromp, Herman H.W. Silljé, Dirk Jan van Veldhuisen, Adriaan A. Voors, Elke S. Hoendermis, Niels Grote Beverborg, Elisabeth‐Maria Schouten, Rudolf A. de Boer et al. · 2018 · Cardiovascular Research
  35. cGMP Signaling and Modulation in Heart Failure
    Robert M. Blanton · 2019 · Journal of Cardiovascular Pharmacology
  36. Heart Failure with Reduced Ejection Fraction (HFrEF) and Preserved Ejection Fraction (HFpEF): The Diagnostic Value of Circulating MicroRNAs
    Yei‐Tsung Chen, Lee Lee Wong, Oi Wah Liew, Mark Richards · 2019 · Cells
  37. The vasculature: a therapeutic target in heart failure?
    Guillermo Luxán, Stefanie Dimmeler · 2021 · Cardiovascular Research
  38. Management of patients with heart failure and preserved ejection fraction
    Alicja Piadlo, Patricia C. Campbell · 2023 · Heart
  39. Cardiovascular Diseases in COPD: From Diagnosis and Prevalence to Therapy
    Anastasia Papaporfyriou, Κonstantinos Bartziokas, Daniela Gompelmann, Marco Idzko, Evangelia Fouka, Stavrina Zaneli, Petros Bakakos, Stelios Loukides, Andriana Ι. Papaioannou · 2023 · Life
  40. Vitamin C as Scavenger of Reactive Oxygen Species during Healing after Myocardial Infarction
    Huabo Zheng, Yichen Xu, Elisa Anamaria Liehn, Mihaela Rusu · 2024 · International Journal of Molecular Sciences
  41. The role of glucagon-like peptide-1 receptor (GLP-1R) agonists in enhancing endothelial function: a potential avenue for improving heart failure with preserved ejection fraction (HFpEF)
    Darshan Hullon, Ghasaq K Subeh, Yelizaveta Volkova, Karolina Janiec, Adam Trach, R.O. Mnevets · 2025 · Cardiovascular Diabetology
  42. A Systematic Review Concerning the Relation between the Sympathetic Nervous System and Heart Failure with Preserved Left Ventricular Ejection Fraction
    Willemien L. Verloop, Martine M. A. Beeftink, Bernadet T. Santema, Michiel L. Bots, Peter J. Blankestijn, Maarten Jan Cramer, Pieter A. Doevendans, Michiel Voskuil · 2015 · PLoS ONE
  43. Extracellular Vesicle Proteins Associated with Systemic Vascular Events Correlate with Heart Failure: An Observational Study in a Dyspnoea Cohort
    Ya-Nan Zhang, Flora Vernooij, Irwani Ibrahim, Shirley Beng Suat Ooi, Crystel M. Gijsberts, Arjan H. Schoneveld, Win Sen Kuan, Hester M. den Ruijter, Leo Timmers, Mark Richards et al. · 2016 · PLoS ONE
  44. Acute Kidney Injury and Risk of Incident Heart Failure Among US Veterans
    Nisha Bansal, Michael Edwin Matheny, Robert A. Greevy, Svetlana Eden, Amy M. Perkins, Sharidan K. Parr, James Fly, Khaled F. M. Abdel-Kader, Jonathan Himmelfarb, Adriana M. Hung et al. · 2017 · American Journal of Kidney Diseases
  45. Protein phosphatase 5 regulates titin phosphorylation and function at a sarcomere-associated mechanosensor complex in cardiomyocytes
    Judith Krysiak, Andreas Unger, Lisa Beckendorf, Nazha Hamdani, Marion von Frieling-Salewsky, Margaret M. Redfield, Cris G. dos Remedios, Farah Sheikh, Ulrich Gergs, Peter Boknı́k et al. · 2018 · Nature Communications
  46. Heart Failure with Preserved Ejection Fraction in Women
    Anjan Tibrewala, Clyde W. Yancy · 2018 · Heart Failure Clinics
  47. Molecular Mechanisms Responsible for Diastolic Dysfunction in Diabetes Mellitus Patients
    Jovana Nikolajević Starčević, Miodrag Janić, Mišo Šabović · 2019 · International Journal of Molecular Sciences
  48. Perturbations in myocardial perfusion and oxygen balance in swine with multiple risk factors: a novel model of ischemia and no obstructive coronary artery disease
    Jens van de Wouw, Oana Sorop, Ruben W. A. van Drie, Richard W. B. van Duin, Isabella Nguyen, Jaap A. Joles, Marianne Christina Verhaar, Daphne Merkus, Dirk Jan Duncker · 2020 · Basic Research in Cardiology
  49. Characterization of Cardiac Sympathetic Nervous System and Inflammatory Activation in HFpEF Patients
    David M. Kaye, Shane Nanayakkara, Bing Wang, Waled Shihata, Francine Z. Marques, Murray Esler, Gavin William Lambert, Justin A. Mariani · 2022 · JACC Basic to Translational Science
  50. Nuanxinkang protects against ischemia/reperfusion-induced heart failure through regulating IKKβ/IκBα/NF-κB-mediated macrophage polarization
    Xin Dong, Jialin Jiang, Zhijun Lin, Ruijia Wen, Ling Zou, Tong Luo, Zhuoji Guan, Xuan Li, Linhai Wang, Lu Lu et al. · 2022 · Phytomedicine
  51. Macrophage-based therapeutic approaches for cardiovascular diseases
    Marida Sansonetti, Bashar Al Soodi, Thomas Thum, Mira Jung · 2024 · Basic Research in Cardiology
  52. Intercellular Communication Lessons in Heart Failure
    Claudia Bang, Charalambos A. Antoniades, Alexios S. Antonopoulos, Ulf Eriksson, Constantijn Franssen, Nazha Hamdani, Lorenz Lehmann, Christine Moessinger, Marco Mongillo, Lars Muhl et al. · 2015 · European Journal of Heart Failure
  53. HFpEF and HFrEF exhibit different phenotypes as assessed by leptin and adiponectin
    Ulrika Ljung Faxén, Camilla Hage, Anna Andréasson, Erwan Donal, Jean‐Claude Daubert, Cecilia Marianne Linde, Kerstin Brismar, Lars H. Lund · 2016 · International Journal of Cardiology
  54. Shared Biomarkers Between Female Diastolic Heart Failure and Pre-Eclampsia: A Systematic Review and Meta-Analysis
    Lisa J. Alma, Anouk Bokslag, Angela H.E.M. Maas, Arie Franx, Walter J. Paulus, Christianne J.M. de Groot · 2017 · ESC Heart Failure
  55. Melatonin improves cardiac function in a mouse model of heart failure with preserved ejection fraction
    Yuan Liu, Lina Li, Sen Guo, Xiaoyan Zhao, Yuzhou Liu, Cui Liang, Sheng Tu, Dan Wang, Ling Li, Jianzeng Dong et al. · 2018 · Redox Biology
  56. Cardiac T1 mapping: Techniques and applications
    Emily Alanna Aherne, Kelvin Chow, James Carr · 2019 · Journal of Magnetic Resonance Imaging
  57. Multimarker Approach Including CRP, sST2 and GDF-15 for Prognostic Stratification in Stable Heart Failure
    Nils Kuster, Fabien Huet, Anne‐Marie Dupuy, Mariama Akodad, Pascal Battistella, Audrey Agullo, Florence Leclercq, Eran Kalmanovich, Alexandra Meilhac, Sylvain Aguilhon et al. · 2020 · ESC Heart Failure
  58. Mechanisms of Diastolic Dysfunction in Heart Failure With a Preserved Ejection Fraction
    Martin M. LeWinter, Markus Meyer · 2013 · Circulation Heart Failure
  59. An overview of radiation-induced heart disease
    Samer H. Ellahham, Amani Khalouf, Mohammed Elkhazendar, Nour Dababo, Yosef Manla · 2022 · Radiation Oncology Journal
  60. Immunometabolism at the Heart of Cardiovascular Disease
    Matthew DeBerge, Rajesh Kumar Chaudhary, Samantha L. Schroth, Edward Benjamin Thorp · 2023 · JACC Basic to Translational Science
  61. Salvianolic acid A alleviates heart failure with preserved ejection fraction via regulating TLR/Myd88/TRAF/NF-κB and p38MAPK/CREB signaling pathways
    Awaguli Dawuti, Shuchan Sun, Ranran Wang, Difei Gong, Ruiqi Liu, Dewen Kong, Tianyi Yuan, Jian Zhou, Yang Lu, Shoubao Wang et al. · 2023 · Biomedicine & Pharmacotherapy
  62. Left ventricular hypertrophy and myocardial fibrosis in heart failure with preserved ejection fraction: mechanisms and treatment
    Alexander Peikert, Marianna Fontana, Scott David Solomon, Thomas Thum · 2025 · European Heart Journal
  63. Aortic Stiffness and Interstitial Myocardial Fibrosis by Native T1 Are Independently Associated With Left Ventricular Remodeling in Patients With Dilated Cardiomyopathy
    Valentina O. Püntmann, Eduardo Arroyo, Rocío Hinojar Baydés, Ning Binti Ngah, Yen‐Shu Kuo, Darius Dabir, Alexandra Macmillan, Ciara Cummins, David M. Higgins, Nicholas Richard Gaddum et al. · 2014 · Hypertension
  64. Current Perspectives on Systemic Hypertension in Heart Failure with Preserved Ejection Fraction
    Marty Tam, Ran Lee, THOMAS M. CASCINO, Matthew C. Konerman, Scott L. Hummel · 2017 · Current Hypertension Reports
  65. Bidirectional Relationship Between Cancer and Heart Failure: Old and New Issues in Cardio-oncology
    Edoardo Bertero, Pietro Ameri, Christoph Maack · 2019 · Cardiac failure review
  66. Effect of Spironolactone on Atrial Fibrillation in Patients with Heart Failure with Preserved Ejection Fraction: Post-Hoc Analysis of the Randomized, Placebo-Controlled TOPCAT Trial
    Jolien Neefs, Nicoline W.E. van den Berg, Sébastien P.J. Krul, S. Matthijs Boekholdt, Joris R. de Groot · 2019 · American Journal of Cardiovascular Drugs
  67. Circulating Vascular Cell Adhesion Molecule‐1 and Incident Heart Failure: The Multi‐Ethnic Study of Atherosclerosis (MESA)
    Ravi B. Patel, Laura Anne Colangelo, Suzette J. Bielinski, Nicholas Bradley Larson, Jingzhong Ding, Norrina B. Allen, Erin D. Michos, Sanjiv Jayendra Shah, Donald M. Lloyd‐Jones · 2020 · Journal of the American Heart Association
  68. GLP-1 receptor agonists as promising anti-inflammatory agents in heart failure with preserved ejection fraction
    Giovanni Battista Bonfioli, Luca Rodella, Marco Metra, Enrico Vizzardi · 2024 · Heart Failure Reviews
  69. Vascular (dys)function in the failing heart
    Luca Liberale, Dirk Jan Duncker, Derek John Hausenloy, Simon C Kraler, Hans Erik Bøtker, Bruno Karl Podesser, Gerd Heusch, Petra Kleinbongard · 2025 · Nature Reviews Cardiology
  70. Arterial calcification: A new perspective?
    Rachel Nicoll, M. Henein · 2016 · International Journal of Cardiology
  71. CSI position statement on management of heart failure in India
    Santanu Guha, S Harikrishnan, Saumitra Ray, Rishi Sethi, S Ramakrishnan, Suvro Banerjee, Vinay Kumar Bahl, Kewal Chand Goswami, Amal Kumar Banerjee, S. Shanmugasundaram et al. · 2018 · Indian Heart Journal
  72. Low-intensity pulsed ultrasound ameliorates cardiac diastolic dysfunction in mice: a possible novel therapy for heart failure with preserved left ventricular ejection fraction
    Yuto Monma, Tomohiko Shindo, Kumiko Eguchi, Ryo Kurosawa, Yuta Kagaya, Yosuke Ikumi, Sadamitsu Ichijo, Takashi Nakata, Satoshi Miyata, Ayana Matsumoto et al. · 2020 · Cardiovascular Research
  73. Association of Coronary Microvascular Dysfunction With Heart Failure Hospitalizations and Mortality in Heart Failure With Preserved Ejection Fraction: A Follow-up in the PROMIS-HFpEF Study
    Camilla Hage, Sara Svedlund, Antti Saraste, Ulrika Ljung Faxén, Lina Benson, Maria Lagerstrom Fermer, Li‐Ming Gan, Sanjiv Jayendra Shah, Carolyn S.P. Lam, Lars H. Lund · 2020 · Journal of Cardiac Failure
  74. Chemokines in cardiac fibrosis
    Ruoshui Li, Nikolaos Georgios Frangogiannis · 2020 · Current Opinion in Physiology
  75. Carbon-11: Radiochemistry and Target-Based PET Molecular Imaging Applications in Oncology, Cardiology, and Neurology
    Sridhar Goud Nerella, Ahana Bhattacharya, Raman Kumar Joshi, Chandana Nagaraj, Rose Dawn Bharath, Pardeep Kumar · 2021 · Journal of Medicinal Chemistry
  76. Device-Based Solutions to Improve Cardiac Physiology and Hemodynamics in Heart Failure With Preserved Ejection Fraction
    Luca Rosalia, Çağlar Öztürk, Saeed Shoar, Yiling Fan, Grainne Malone, Faisal Habib Cheema, Claire Conway, Robert A. Byrne, Garry P. Duffy, Andrew J. Malone et al. · 2021 · JACC Basic to Translational Science
  77. Sex Differences in Cardiometabolic Traits and Determinants of Exercise Capacity in Heart Failure With Preserved Ejection Fraction
    Emily S. Lau, Thomas Cunningham, Kathryn M. Hardin, Elizabeth E. Liu, Rajeev Kumar Malhotra, Matthew Gregory Nayor, Gregory D. Lewis, Jennifer E. Ho · 2019 · JAMA Cardiology
  78. An herbal preparation ameliorates heart failure with preserved ejection fraction by alleviating microvascular endothelial inflammation and activating NO-cGMP-PKG pathway
    Yuting Huang, Kai Zhang, Miao Liu, Jing Su, Xiao‐Yan Qin, Xiao Wang, Jing Zhang, Sheng Li, Guanwei Fan · 2021 · Phytomedicine
  79. Traditional Chinese medicine as a therapeutic option for cardiac fibrosis: Pharmacology and mechanisms
    Xiao Li, Lin Li, Wei Lei, Hui Zi Chua, Zining Li, Xianglong Huang, Qilong Wang, Nan Li, Han Zhang · 2021 · Biomedicine & Pharmacotherapy
  80. Insulin-Like Growth Factor Binding Protein 7 (IGFBP7), a Link Between Heart Failure and Senescence
    Valentina Bračun, Bart J. van Essen, Adriaan A. Voors, Dirk Jan van Veldhuisen, Kenneth Dickstein, Faiez M. Zannad, Marco Metra, Stefan D. Anker, Nilesh J. Samani, Piotr P. Ponikowski et al. · 2022 · ESC Heart Failure
  81. Blood pressure and childhood obstructive sleep apnea: A systematic review and meta-analysis
    Sizhi Ai, Zhexi Li, Shanshan Wang, Sijing Chen, Joey Wing Yan Chan, Chun Ting Au, Yanping Bao, Albert Martin Li, Jihui Zhang, Kate Ching Ching Chan et al. · 2022 · Sleep Medicine Reviews
  82. Myeloperoxidase Inhibition Reverses Biomarker Profiles Associated With Clinical Outcomes in HFpEF
    Erik Michaëlsson, Lars H. Lund, Camilla Hage, Sanjiv Jayendra Shah, Adriaan A. Voors, Antti Saraste, Björn Redfors, Erik Lerkevang Grove, Anders L Barasa, Mark Richards et al. · 2023 · JACC Heart Failure
  83. Coronary Microvascular Dysfunction in Patients With Heart Failure: Characterization of Patterns in HFrEF Versus HFpEF
    Pasquale Paolisso, Emanuele Gallinoro, Marta Belmonte, Dario Tino Bertolone, Konstantinos Bermpeis, Cristina De Colle, Monika Shumkova, Attilio Leone, Serena Caglioni, Giuseppe Esposito et al. · 2023 · Circulation Heart Failure
  84. Patients with heart failure with preserved ejection fraction and low levels of natriuretic peptides
    Wouter C. Meijers, Tialda Hoekstra, Tiny Jaarsma, Dirk Jan van Veldhuisen, Rudolf A. de Boer · 2016 · Netherlands Heart Journal
  85. Five-year changes in cardiac structure and function in patients with rheumatoid arthritis compared with the general population
    John M. Davis, Grace Lin, Jae K. Oh, Cynthia S. Crowson, Sara J. Achenbach, Terry M. Therneau, Eric L. Matteson, Richard J. Rodeheffer, Sherine E. Gabriel · 2017 · International Journal of Cardiology
  86. Osteoglycin prevents the development of age-related diastolic dysfunction during pressure overload by reducing cardiac fibrosis and inflammation
    Sophie Deckx, Ward Heggermont, Paolo Carai, Marieke Rienks, Tom Dresselaers, Uwe Himmelreich, Rick E.W. van Leeuwen, Wies Lommen, Jolanda van der Velden, Arantxa González et al. · 2017 · Matrix Biology
  87. Subclinical hypothyroidism and the development of heart failure: an overview of risk and effects on cardiac function
    Agata Magdalena Bielecka-Dabrowa, Breno Godoy, Tsuyoshi Suzuki, Maciej Banach, Stephan von Haehling · 2018 · Clinical Research in Cardiology
  88. Vitamin K–Dependent Matrix Gla Protein as Multifaceted Protector of Vascular and Tissue Integrity
    Fang‐Fei Wei, Sander Trenson, Peter B. Verhamme, Cees Vermeer, Jan Albert Staessen · 2019 · Hypertension
  89. Reappraisal of Inflammatory Biomarkers in Heart Failure
    Thanat Chaikijurajai, W.H. Wilson Tang · 2020 · Current Heart Failure Reports
  90. Incident Hospitalization with Major Cardiovascular Diseases and Subsequent Risk of ESKD: Implications for Cardiorenal Syndrome
    Junichi Ishigami, Logan Cowan, Ryan T. Demmer, Morgan Erika Grams, Pamela L. Lutsey, Juan Jesús Carrero, Josef Coresh, Kunihiro Matsushita · 2020 · Journal of the American Society of Nephrology
  91. The Importance of Natriuretic Peptides in Cardiometabolic Diseases
    Shravya Vinnakota, Horng H. Chen · 2020 · Journal of the Endocrine Society
  92. Role of Inflammation in Coronary Epicardial and Microvascular Dysfunction
    Shigeo Godo, JUN C. TAKAHASHI, Satoshi Yasuda, Hiroaki Shimokawa · 2021 · European Cardiology Review
  93. Diabetic Cardiomiopathy Progression is Triggered by miR122-5p and Involves Extracellular Matrix
    Riccardo Pofi, Elisa Giannetta, Nicola Galea, Marco Francone, Federica Campolo, Federica Barbagallo, Daniele Gianfrilli, Mary Anna Venneri, Tiziana Filardi, Cristiano Vincenzo Emilio Cristini et al. · 2020 · JACC. Cardiovascular imaging
  94. Current Understanding of Molecular Pathophysiology of Heart Failure With Preserved Ejection Fraction
    Heidi Budde, Roua Hassoun, Andreas Mügge, Árṕad Kov́acs, Nazha Hamdani · 2022 · Frontiers in Physiology
  95. Coronary Artery Disease and Heart Failure With Preserved Ejection Fraction: The ARIC Study
    Jenine E. John, Brian Lee Claggett, Hicham Skali, Scott David Solomon, Jonathan W. Cunningham, Kunihiro Matsushita, Suma Konety, Dalane W. Kitzman, Thomas H. Mosley, Donald Clark et al. · 2022 · Journal of the American Heart Association
  96. Prevalence and incidence of diastolic dysfunction in atrial fibrillation: clinical implications
    Jwan A. Naser, Eunjung Lee, Christopher G. Scott, Austin M Kennedy, Patricia A. Pellikka, Grace Lin, Sorin V. Pislaru, Barry A. Borlaug · 2023 · European Heart Journal
  97. Heart Failure with Preserved Ejection Fraction: The Pathophysiological Mechanisms behind the Clinical Phenotypes and the Therapeutic Approach
    Laurențiu Stoicescu, Dana Crișan, Claudiu Morgovan, Lucreția Avram, Stéliana Ghibu · 2024 · International Journal of Molecular Sciences
  98. High-sensitivity C-reactive protein in heart failure with preserved ejection fraction: Findings from TOPCAT
    João Pedro Ferreira, Brian Lee Claggett, Jiankang Liu, Abhinav Sharma, Akshay Suvas Desai, Inder S. Anand, Eileen O’Meara, Jean Lucien Rouleau, Simon de Denus, Bertram Pitt et al. · 2024 · International Journal of Cardiology
  99. Comorbidities in Heart Failure: Are There Gender Differences?
    Ingrid Hopper, Dipak Kotecha, Ken Lee Chin, Robert John Mentz, Thomas G. von Lueder · 2016 · Current Heart Failure Reports
  100. Is enhancing cGMP-PKG signalling a promising therapeutic target for heart failure with preserved ejection fraction?
    Árṕad Kov́acs, Alessio Alogna, Heiner Post, Nazha Hamdani · 2016 · Netherlands Heart Journal